Back to search
Complement 3 Glomerulopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Complement 3 Glomerulopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Complement 3 Glomerulopathy trials you may qualify forThis is a Phase 2 study to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics of ADX-038 in adults with complement-mediated kidney diseases…
The Primary Completion Date and Study Completion Date have been updated to reflect completion of the adolescent cohort, which has been added to the protocol. T…
This is a multicenter, single arm, open-label, extension study to evaluate the long-term safety, tolerability, and efficacy of iptacopan in participants with aH…
This is a Phase 2, multicenter, open-label, randomized, controlled study designed to evaluate the safety and efficacy of pegcetacoplan in patients who have post…
This study is designed as a long-term extension to Study APL2-C3G-310, and is being conducted to establish the long-term safety and efficacy of pegcetacoplan in…